Botanical species · safety record

Vigna angularis

The EFSA Compendium of Botanicals holds 7 constituent measurements and 1 adverse-effect record for Vigna angularis. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Vigna angularis (Willd.) Ohwi & H. Ohashi

7Constituent measurements

1Safety records

4Cited sources

38Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 38 licensed products naming Vigna angularis as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Dry
Extract Type TBA

Source material stated

New material
Seed
Seed(s)
Sprout(s)

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Trigonelline	Sprout	Solvent extraction	≥ 0.62 Milligram/gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Trigonelline	Sprout	Solvent extraction	≤ 0.66 Milligram/gram	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	Resolve DOI
Daidzein	Seed	Solvent extraction	≥ 4.97 Microgram/gram	HPLC-DAD	No resolvable identifier
Daidzein	Seed	Solvent extraction	≤ 5.7 Microgram/gram	HPLC-DAD	No resolvable identifier
Genistein	Seed	Solvent extraction	≤ 3.55 Microgram/gram	HPLC-DAD	No resolvable identifier
Genistein	Seed	Solvent extraction	≥ 3.44 Microgram/gram	HPLC-DAD	No resolvable identifier
Tannins	Seed	Solvent extraction	15 Percent	Unspecified	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive	Seed	Solvent extraction	—	In vitro	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Nakamura, Yumiko., Kaihara, Akiko., Yoshii, Kimihiko., Tsumura, Yukari., Ishimitsu, Susumu., Tonogai, Yasuhide. Content and composition of isoflavonoids in mature or immature beans and bean sprouts consumed in Japan. Journal of health science, 2001, vol. 47, no. 4, p. 394-406.
Yao, Yang., Cheng, Xuzhen., Wang, Lixia., Wang, Suhua., Ren, Guixing. A Determination of Potential alpha-Glucosidase Inhibitors from Azuki Beans (Vigna angularis) . International journal of molecular sciences, 2011, vol. 12, no. 10, p. 6445-6451. DOI
Rozan, P., Kuo, YH., Lambein, F. Free amino acids present in commercially available seedlings sold for human consumption. A potential hazard for consumers . Journal of agricultural and food chemistry, 2000, vol. 48, no. 3, p. 716-723. DOI
Ito, Yasuzo., Kawahara, Noriyuki., Murakami, Tomoko. A cooking method for azuki beans. V. Thin layer chromatography and infrared spectrum of flavanol tannin. Hokkaido kyoiku daigaku kiyo, dai-2-bu, a: sugaku, butsuri, kagaku, kogaku hen, 1984, vol. 35, no. 1, p. 53-9.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature